Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Core Viewpoint - Axogen, Inc. is set to release its financial results for Q4 and the full year 2025 on February 24, 2026, followed by a conference call for the investment community [1]. Company Overview - Axogen, Inc. is a leader in developing and marketing surgical solutions aimed at restoring peripheral nerve function, with a mission to establish nerve repair as the standard of care [3]. - The company focuses on the science, development, and commercialization of technologies for peripheral nerve repair, collaborating with surgeons and healthcare providers globally [3]. Product Portfolio - Axogen's product offerings include: - Avance® (acellular nerve allograft-arwx) - Avance® Nerve Graft - Axoguard Nerve Connector® - Axoguard Nerve Protector® - Axoguard HA+ Nerve Protector™ - Axoguard Nerve Cap® - Avive+ Soft Tissue Matrix™ [4].